Callahan Advisors LLC Sells 10,302 Shares of Corteva, Inc. $CTVA

Callahan Advisors LLC trimmed its position in Corteva, Inc. (NYSE:CTVAFree Report) by 6.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 139,237 shares of the company’s stock after selling 10,302 shares during the period. Callahan Advisors LLC’s holdings in Corteva were worth $9,333,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in Corteva by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after purchasing an additional 317,538 shares during the period. State Street Corp increased its holdings in Corteva by 3.6% in the third quarter. State Street Corp now owns 35,280,805 shares of the company’s stock valued at $2,386,041,000 after purchasing an additional 1,230,074 shares during the period. Franklin Resources Inc. increased its holdings in Corteva by 5.9% in the third quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company’s stock valued at $1,266,820,000 after purchasing an additional 1,051,389 shares during the period. Northern Trust Corp increased its holdings in Corteva by 1.8% in the third quarter. Northern Trust Corp now owns 11,169,284 shares of the company’s stock valued at $755,379,000 after purchasing an additional 194,728 shares during the period. Finally, Legal & General Group Plc increased its holdings in Corteva by 14.3% in the third quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock valued at $389,142,000 after purchasing an additional 720,469 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.15% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CTVA has been the subject of a number of recent research reports. Royal Bank Of Canada increased their price objective on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Argus increased their price objective on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, Mizuho increased their price target on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $88.14.

Read Our Latest Analysis on CTVA

Corteva Stock Performance

Shares of CTVA opened at $78.77 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock has a 50-day moving average of $81.25 and a 200-day moving average of $73.79. The company has a market cap of $52.68 billion, a PE ratio of 46.33, a P/E/G ratio of 2.42 and a beta of 0.59. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.

Corteva (NYSE:CTVAGet Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.